MV Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $47.8K | Sell |
118
-87
| -42% | -$35.3K | ﹤0.01% | 307 |
|
2025
Q1 | $102K | Sell |
205
-19
| -8% | -$9.45K | 0.01% | 236 |
|
2024
Q4 | $117K | Sell |
224
-7
| -3% | -$3.64K | 0.01% | 214 |
|
2024
Q3 | $143K | Buy |
231
+10
| +5% | +$6.19K | 0.02% | 200 |
|
2024
Q2 | $122K | Buy |
221
+22
| +11% | +$12.2K | 0.01% | 203 |
|
2024
Q1 | $116K | Buy |
199
+23
| +13% | +$13.4K | 0.01% | 209 |
|
2023
Q4 | $93.4K | Sell |
176
-1
| -0.6% | -$531 | 0.01% | 227 |
|
2023
Q3 | $89.6K | Sell |
177
-14
| -7% | -$7.09K | 0.01% | 220 |
|
2023
Q2 | $99.7K | Sell |
191
-14
| -7% | -$7.31K | 0.01% | 214 |
|
2023
Q1 | $118K | Buy |
205
+47
| +30% | +$27.1K | 0.02% | 187 |
|
2022
Q4 | $87K | Sell |
158
-17
| -10% | -$9.36K | 0.01% | 177 |
|
2022
Q3 | $89K | Buy |
175
+46
| +36% | +$23.4K | 0.02% | 170 |
|
2022
Q2 | $70K | Sell |
129
-5
| -4% | -$2.71K | 0.01% | 194 |
|
2022
Q1 | $79K | Hold |
134
| – | – | 0.01% | 188 |
|
2021
Q4 | $89K | Buy |
134
+28
| +26% | +$18.6K | 0.01% | 173 |
|
2021
Q3 | $61K | Buy |
106
+45
| +74% | +$25.9K | 0.01% | 193 |
|
2021
Q2 | $31K | Buy |
61
+52
| +578% | +$26.4K | 0.01% | 240 |
|
2021
Q1 | $4K | Buy |
+9
| New | +$4K | ﹤0.01% | 279 |
|
2020
Q2 | – | Sell |
-21
| Closed | -$6K | – | 352 |
|
2020
Q1 | $6K | Hold |
21
| – | – | ﹤0.01% | 239 |
|
2019
Q4 | $7K | Hold |
21
| – | – | ﹤0.01% | 269 |
|
2019
Q3 | $6K | Hold |
21
| – | – | ﹤0.01% | 276 |
|
2019
Q2 | $6K | Sell |
21
-2
| -9% | -$571 | ﹤0.01% | 269 |
|
2019
Q1 | $6K | Buy |
+23
| New | +$6K | ﹤0.01% | 277 |
|